【レポートの概要（一部）】
1. Report Overview
1.1 Pharma Contract Manufacturing: World Market Overview
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by This Analysis
1.5 Who is This Study For?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain
2. Pharma Contract Manufacturing
2.1 An Introduction to Pharma Contract Manufacturing
2.1.1 Why Outsource in the Pharma Industry?
2.1.2 Services Offered by CMOs
2.1.3 Tactical and Strategic Manufacturing Outsourcing
2.1.4 Trends in Contract Manufacturing 2015-2025
3. The Pharma Contract Manufacturing Market: Outlook and Forecast 2015-2025
3.1 The Pharma Contract Manufacturing: Market Performance 2012-2013
3.1.1 Contract Manufacturing Is the Most Mature Pharma Outsourcing Sector
3.1.2 The Pharma Contract Manufacturing Market by Sector 2013
3.2 Pharma Contract Manufacturing: Overall Market Forecast 2015-2025
3.2.1 What Will Drive Growth for Contract Manufacturers 2015-2025?
3.2.2 Will Generics Drive or Restrain Market Growth?
3.2.3 Outlook and Revenue Forecast for Other Contract Manufacturing Services 2015-2025
3.2.3.1 Rising Demand for Formulation Development Services
3.3 Clinical and Commercial Manufacturing Services
3.3.1 Clinical-Stage Manufacturing: Submarket Forecast 2015-2025
3.3.2 Commercial-Stage Manufacturing: Submarket Forecast 2015-2025
3.4 Leading Contract Manufacturing Organisations (CMOs)
3.4.1 Catalent Pharma Solutions: The Market Leader
3.4.1.1 Expanding in Clinical and Biopharma Manufacturing
3.4.2 Lonza: An Expert in Biopharma Manufacturing
3.4.2.1 Lonza and Advanced Biopharma Manufacturing
3.4.3 Evonik Degussa: A Small Molecule Specialist
3.4.3.1 Growth in HPAPI Manufacturing
3.4.4 Royal DSM
3.4.4.1 Adding Biopharma Capacity
3.4.5 Teva API: The World’s Largest API Manufacturer
3.4.5.1 Will Teva Expand in Emerging Markets?
3.4.6 Patheon
3.4.6.1 Patheon Is Adding New Formulation Development Services
3.4.7 Boehringer BioXcellence: Boehringer’s Biopharma Manufacturing Division
3.4.7.1 Adding New Services for Growth
3.4.8 Famar
3.4.9 Fareva
3.4.10 Vetter Pharma: Aseptic Filling for Biologics and Small Molecules
3.4.10.1 Vetter Offers its Clients New Services
4. The Contract API Manufacturing Submarket: Outlook 2015-2025
4.1 The Contract API Manufacturing Submarket 2013
4.1.1 The API Manufacturing Submarket by Sector 2013
4.2 The Contract API Manufacturing Submarket Outlook 2014-2025
4.2.1 The Contract API Manufacturing Submarket Forecast 2015-2025
4.2.2 What Will Drive Submarket Growth to 2025?
4.2.2.1 The Potential for Microreactors in Commercial Manufacturing to 2025
4.2.3 How Will New EU Regulations Impact the API Manufacturing Submarket?
4.2.4 Contract API Manufacturing Submarket Restraints 2015-2025
4.2.4.1 Backwards Integration for Generics Manufacturers
4.3 The Contract Generic API Manufacturing Submarket 2015-2025
4.3.1 The Contract Generic API Manufacturing Submarket Forecast 2015-2025
4.3.2 The Contract Generic API Manufacturing Submarket Drivers and Restraints to 2025
4.3.2.1 The US Generic Drug User Fee Act and API Manufacturing
4.4 The Contract HPAPI Manufacturing Submarket 2015-2025
4.4.1 Challenges and Opportunities in High Containment Manufacturing
4.4.2 Many Companies Are Investing in HPAPI Manufacturing Facilities
4.4.3 The Contract HPAPI Manufacturing Submarket Forecast 2015-2025
4.4.4 Submarket Drivers and Restraints 2015-2025
5. The Contract FDF Manufacturing Submarket Outlook 2015-2025
5.1 The Contract FDF Manufacturing Submarket 2013
5.1.1 Solid Dosage Manufacturing Leads the Market
5.1.2 CMOs Report High Demand for Softgel Formulations
5.2 The Contract FDF Manufacturing Submarket Forecast 2015-2025
5.2.1 Complex Molecule Manufacturing Will Drive Growth to 2025
5.2.2 What Will Restrain Growth in FDF Outsourcing?
5.3 The Contract Solid Dosage Manufacturing Submarket 2015-2025
5.3.1 How Will Revenues for Solid Dosage Manufacturing Grow 2015-2025?
5.3.2 Submarket Drivers and Restraints 2015-2025
5.3.2.1 Will Product Reformulation Drive Growth to 2025?
5.4 The Contract Injectable Dosage Manufacturing Submarket 2015-2025
5.4.1 The Contract Injectable Dosage Manufacturing Submarket Forecast 2015-2025
5.4.1.1 Drug Shortages Offer an Opportunity for CMOs in the Short Term
5.4.2 Demand for Biopharma Manufacturing Will Drive Growth 2015-2025
5.4.2.1 Interest in Antibody Drug Conjugate Development Is Growing
5.4.2.2 Challenges in Manufacturing Antibody Drug Conjugates
5.4.3 Lyophilisation and Aseptic Filling Demand Will Rise
5.4.3.1 Will Spray Drying Replace Lyophilisation in FDF Manufacturing?
6. Pharma Contract Manufacturing: Leading Developed National Markets 2015-2025
6.1 Leading National Markets for Pharma Contract Manufacturing 2013
6.1.1 Challenges in Assessing the Market: Supply vs. Demand
6.1.2 Leading National Pharma Contract Manufacturing Markets: Revenue Forecasts 2015-2025
6.2 The US Is the Leading National Market in Terms of Demand
6.2.1 Pharma Manufacturing in the US: Regulatory Oversight 2013
6.2.1.1 Controlling Foreign Manufacturing Sites
6.2.1.2 What Impact Will the GDUFA 2012 Have on Foreign Manufacturing?
6.2.1.3 Outsourcing and US Manufacturing Regulations
6.2.2 Increased Demand for Domestic API Manufacturing?
6.2.3 The US Contract Manufacturing Submarket Forecast 2015-2025
6.3 Outlook for Pharma Contract Manufacturing in the EU
6.3.1 The EU is the Leading Destination for Pharma Contract Manufacturing
6.3.2 Regulatory Aspects to Pharma Manufacturing in the EU
6.3.2.1 The European Commission Amends Annex 16
6.3.2.2 The Falsified Medicine Directive: Controlling API Imports
6.3.3 Biopharma Manufacturing Demand Will Rise to 2025
6.3.4 The EU Contract Manufacturing Submarket Forecast 2015-2025
6.3.5 Germany: The Leading EU Destination for API and FDF Manufacturing
6.3.5.1 Demand for Contract Manufacturing in Germany: Revenue Forecast 2015-2025
6.3.6 CMOs Account for a Third of Manufacturing Sites in France
6.3.6.1 French Pharma Contract Manufacturing Submarket Forecast 2015-2025
6.3.7 Italy: Strong API Manufacturing Traditions
6.3.7.1 Revenue Forecast for the Italian Pharma Contract Manufacturing Submarket 2015-2025
6.3.8 Spain: How Will Demand for Manufacturing Services Grow to 2025?
6.3.9 The UK: Pharma Contract Manufacturing Submarket Forecast 2015-2025
6.4 Pharma Contract Manufacturing in Japan 2015-2025
6.4.1 Pharma Manufacturing Regulations in Japan
6.4.1.1 The Pharmaceutical Affairs Law
6.4.2 Greater API Outsourcing to Drive Japanese Submarket Growth to 2025
7. Pharma Contract Manufacturing: Leading Emerging National Markets 2015-2025
7.1 Pharma Contract Manufacturing in Developing Countries
7.1.1 Outsourcing to Emerging National Markets from Developed Markets
7.1.1.1 Demand for Services in India and China
7.1.2 Domestic Demand for Pharma Contract Manufacturing Services
7.1.3 Pharma Contract Manufacturing: Leading Emerging National Market Forecasts 2015-2025
7.2 Chinese Demand for Pharma Contract Manufacturing Services 2015-2025
7.2.1 Improved Manufacturing Regulations in China
7.2.1.1 New Regulations for Excipients and Guidance for API Manufacturing 2012-2013
7.2.1.2 What Are the Consequences to Stricter Manufacturing Regulations in China?
7.2.2 Chinese CMOs Are Investing in Biopharma Manufacturing
7.2.3 China Pharma Contract Manufacturing Submarket Forecast 2015-2025
7.3 India: CMOs with Growing Formulation Experience
7.3.1 Regulatory Outlook for Indian Pharma Manufacturing
7.3.1.1 Ensuring Compliance with New Rules in the EU
7.3.2 Domestic Manufacturing Dominates the Indian Pharma Market
7.3.3 Demand for Contract Manufacturing in India: Submarket Forecast 2015-2025
7.4 Brazil: Contract Manufacturing Outlook 2013-2025
7.4.1 Pharma Manufacturing Regulations in Brazil
7.4.1.1 New Guidelines and Regulations Proposed 2012-2013
7.4.2 Brazil Imports Most of its APIs
7.4.3 Brazil: Pharma Contract Manufacturing Submarket Forecast 2015-2025
7.5 The Russian Pharma Contract Manufacturing Submarket 2015-2025
7.5.1 Pharma Manufacturing Regulations in Russia
7.5.1.1 Compliance with GMP in Russia
7.5.2 How Will Demand for Contract Manufacturing Grow in Russia 2015-2025?
7.6 South Korea
7.6.1 South Korea: Strict GMP Regulations
7.6.2 South Korea: Pharma Contract Manufacturing Submarket Forecast 2015-2025
8. Pharma Contract Manufacturing Industry Trends: CMO Perspective 2015-2025
8.1 Pharma Contract Manufacturing Market: Strengths and Weaknesses for CMOs 2013-2014
8.2 Pharma Contract Manufacturing Market: Opportunities and Threats for CMOs 2015-2025
8.3 Pharma Contract Manufacturing Market: STEP Analysis 2015-2025
8.3.1 Social Factors
8.3.2 New Technologies Will Drive Market Growth to 2025
8.3.2.1 Single-Use Technologies in Biopharma Manufacturing
8.3.2.2 Green Technology in Contract Manufacturing
8.3.2.3 Drug Delivery Trends and CMOs
8.3.2.4 Biologics Are Causing Increased Demand for Lyophilisation
8.3.2.5 Improving Solubility and Stability for Small Molecules
8.3.2.6 Spray Drying as an Alternative to Lyophilisation
8.3.2.7 Hot-Melt Extrusion
8.3.3 Economic Pressures
8.3.3.1 Developed-Market CMOs Face Competition from Emerging Markets
8.3.4 Political Issues
8.3.4.1 How Will Regulatory Developments Affect CMOs?
8.4 Trends in Drug Development Affecting CMOs to 2025
8.4.1 Orphan Drug Development: Smaller Manufacturing Capacities
8.4.2 Complex Biologics: Interest in ADCs is Rising
8.4.3 How Will Biosimilar Market Growth Affect CMOs?
8.4.4 The Future of Small Molecule Outsourcing
8.5 How Will CMOs Expand in the Coming 10 Years?
8.5.1 CMO Consolidation Will Increase
8.5.2 There Will be More Manufacturing Facilities Available for Acquisition
8.6 Developments in the Manufacturing Process 2015-2025
8.6.1 Quality by Design (QbD)
8.6.2 A Move Towards Continuous Manufacturing?
9. Pharma Contract Manufacturing Industry Trends: Client Perspective 2015-2025
9.1 Pharma Contract Manufacturing: Client Perspective Industry Strengths and Weaknesses 2013-2014
9.2 Pharma Contract Manufacturing: Client Perspective Industry Opportunities and Threats 2015-2025
9.3 Important Aspects of the Outsourcing Decision
9.3.1 What Factors Will Influence CMO Selection?
9.3.2 CMO-Pharma Partnering Models
9.3.3 Strategic Partnering
9.3.4 Selecting a Local CMO vs. Offshoring
9.3.5 CMOs in Emerging Markets
9.3.6 Communication
9.3.7 Ensuring Protection in Intellectual Property and Tech Transfer
9.3.8 Regulatory Compliance is a Key Deciding Factor for Pharma Clients
9.3.8.1 Regulatory Bodies and Outsourcing
9.3.8.2 Quality Agreement
9.3.8.3 Global Harmonisation Will Improve Compliance
9.4 Trends in Outsourcing Partnerships 2015-2025
9.4.1 Big Pharma and Outsourced Manufacturing
9.4.2 Small and Virtual Pharma Companies
9.4.3 How Will Biotech Funding Affect the Pharma Contract Manufacturing Industry to 2025?
10. Research Interviews from Our Industry Survey
10.1 Dr Cynthia Wooge, Global Strategic Marketing Manager, SAFC
10.1.1 SAFC
10.1.2 Are ADCs Limited to Oncology?
10.1.3 The Challenges of ADCs Manufacturing
10.1.4 What Solution Does SAFC Offer for ADCs Manufacturing?
10.1.5 Advancement in Conjugation Technology
10.2 Mr. Peter Soelkner, Managing Director of Vetter Pharma International GmbH
10.2.1 Vetter
10.2.2 Singapore, a Global Biomedical Sciences Hub
10.2.3 Market Outlook for APAC Region
10.2.4 Challenges to Be Addressed in the APAC Region
11. Conclusions of the Study
11.1 The World Pharma Contract Manufacturing Market
11.2 Outlook for the Market to 2025
11.2.1 Rising Demand for High Value Services 2015-2025
11.2.2 Demand Will be Highest Among Developed Market Clients
11.3 Which New Technologies Will Stimulate Demand to 2025?
【レポート販売概要】
■ タイトル：医薬品製造受託（CMO）サービスの世界市場■ 英文：Pharmaceutical Contract Manufacturing: World Industry and Market Outlook 2015-2025
■ 発行日：2015年2月
■ 調査会社：visiongain
■ 商品コード：VGAIN502207
■ 調査対象地域：グローバル
- 炭素繊維プリプレグの世界市場The global carbon fiber prepreg market was valued at $2,633.0 million in 2014 and is estimated to reach $4,640.2 million by 2019, at a CAGR of 11.9% during the period under consideration. In this report, the global carbon fiber prepreg market has been broadly classified on the basis of application and geography. The application segment is divided into aerospace & defense, wind, sporting goods, and …
- 汚泥処理用化学薬品の世界市場：凝集剤、凝固剤、消毒薬、消泡剤、活性炭Industrial sludge originates from the process of treatment of waste water. Owing to the physical-chemical processes involved in the treatment, the sludge tends to concentrate heavy metals as well as poorly biodegradable trace organic compounds and potentially pathogenic organisms (viruses, bacteria and so on) present in waste waters. Industrial sludge treatment play a very important role in the ef …
- 世界のフェノキシエタノール防腐剤市場2015The Global Phenoxyethanol Preservatives Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Phenoxyethanol Preservatives industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Phenoxyethanol Preservatives market analysis is provided for the international m …
- ビジネス情報サービスの世界市場2015-2019About Business Information Business information services provide various forms of content including information on M&A; news; market research; financial, legal, marketing, and credit information; and healthcare and current awareness news. These services are offered by business information providers on a subscription basis for a monthly or yearly fee. Business professionals rely on business informa …
- ヘアミスト・ボディミストの世界市場2016-2020About Global Hair and Body Mist Market The global hair and body mist market will grow at a gradual rate over the forecast period. Although the market will be affected by a slowdown in demand in key countries like the US, Germany, the UK, France, Italy, Spain, and Japan as they near maturity, this will be offset by a strengthening of demand in developing countries such as Brazil, India, Malaysia, a …
- Hydrogenated Bisphenol Aの世界市場Hydrogenated Bisphenol A (CAS 80-04-6) Market Research Report 2013 presents comprehensive data on hydrogenated bisphenol a markets globally and regionally (Europe, Asia, North America etc.) The report includes hydrogenated bisphenol a description, covers its application areas and related patterns. It overviews hydrogenated bisphenol a market, names hydrogenated bisphenol a producers and indicates …
- 有機顔料の世界市場2017-2021： アゾ顔料、フタロシアニン顔料、その他有機顔料About Organic Pigment Pigments are soluble colorants that are usually in the powder form. Pigments are derived from minerals. They can be produced synthetically as well. Pigments offer enormous options in terms of color. They have better color retention properties in comparison with dyes. Pigments add value in terms of visual appeal and durability to various products such as textiles, food product …
- 群知能（SI）の世界市場予測（～2030年）The swarm intelligence market is expected to be valued at USD 447.2 Million by 2030, growing at a CAGR of 40.47% from 2020 to 2030, considering the technology will get commercialized by 2020. The major factors driving the growth of this market include the increasing usage of swarm intelligence for solving big data problems and the rising adoption of swarm-based drones in the military. In transport …
- 湿度センサーの世界市場2018-2022About Humidity Sensor A humidity sensor measures and reports relative humidity in the atmosphere. It measures both air temperature and moisture content in the surrounding atmosphere. Technavio’s analysts forecast the global humidity sensor market to grow at a CAGR of 12.07% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the gl …
- 化粧品包装の世界市場予測2016-2026The global cosmetics packaging market is expected to be driven by a multitude of factors such as increasingly busy lifestyles resulting in more convenient packaging, people increasingly conscious about their looks, an ageing population driving the demand for anti-ageing products, the increase in male grooming, fast growth in emerging economies and Increasing demand for natural and organic cosmetic …
- セリアック病(Celiac Disease)：世界の治験レビュー（2015年上半期版）Celiac Disease Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Celiac Disease Global Clinical Trials Review, H1, 2015" provides data on the Celiac Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Celiac Disease. It includes an overview of the trial numbers and their recruitment status as per …
- 流体管理システムの世界市場予測2021：透析器、注入器、流体加温装置、圧力変換器、吸収缶The fluid management systems and accessories market is projected to reach USD 12.47 Billion by 2021 from USD 9.39 Billion in 2016, at a CAGR of 5.8% during the forecast period. Factors such as increasing number of minimally invasive surgeries, technological advancements in fluid management systems, and increase in government funds and grants worldwide for endosurgical procedures are driving the ma …
- 世界の血液型検査/分類、感染症スクリーニング検査（医療機器）市場This unique report from Venture Planning Group provides sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test and country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, co …
- ダイアライザーの世界市場2017-2021About DialyzerThe dialyzer, also known as artificial kidney, is a medical device that is used as a filter in the dialysis process for individuals suffering from renal failure. It consists of the filter membrane, which allows the impure blood to pass through and purifies the blood. Technavio’s analysts forecast the global dialyzer market to grow at a CAGR of 5.98% during the period 2017-2021. [Cove …
- クラウド型統合プラットフォームサービスの世界市場予測（～2021年）The Integration Platform as a Service market is expected to grow from USD 528.0 Million in 2016 to USD 2,998.3 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 41.5% during the forecast period. The demand for iPaaS is driven by factors such as the need for business agility, faster deployment & scalability, increasing awareness about iPaaS among enterprises globally, and reduced cost of …
